Empyrean Medical Systems Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Empyrean Medical Systems's estimated annual revenue is currently $5.1M per year.(i)
  • Empyrean Medical Systems's estimated revenue per employee is $150,441

Employee Data

  • Empyrean Medical Systems has 34 Employees.(i)
  • Empyrean Medical Systems grew their employee count by 26% last year.

Empyrean Medical Systems's People

NameTitleEmail/Phone
1
Founder, President & CEOReveal Email/Phone
2
Chief Technology OfficerReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
Chief PhysicistReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
Head Systems HardwareReveal Email/Phone
7
VP Sales and Market Development (Oncology)Reveal Email/Phone
8
Director, Clinical Applications, Customer Experience and Patient AdvocacyReveal Email/Phone
9
Commercial Project ManagerReveal Email/Phone
10
Principal Software Quality Systems EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.3M9315%N/AN/A
#2
N/A100%N/AN/A
#3
$1.1M60%N/AN/A
#4
$3.7M2420%N/AN/A
#5
$4.3M259%N/AN/A
#6
$2.5M16N/AN/AN/A
#7
$0.8M40%N/AN/A
#8
$1.1M60%N/AN/A
#9
$2.5M148%N/AN/A
#10
$1.4M3-57%N/AN/A
Add Company

What Is Empyrean Medical Systems?

Empyrean Medical Systems, Inc. was founded to fundamentally transform the way cancer patients are being treated when faced with such a life-altering experience. We take cancer on all its forms personally and with utmost vengeance. Our families, friends, and communities were all inflicted by this phantom disease, which now reached pandemic proportions. We live and work every single day to make a real difference for our patients, their families, and our clinicians all around the world.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$5.1M

Revenue (est)

26%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6M3431%N/A
#2
$1.7M34-11%N/A
#3
$8M343%N/A
#4
$6.9M3413%N/A
#5
$7.3M3421%N/A